results of a phase ib study of ibrutinib obinutuzumab in r/r cll
Published 2 years ago • 132 plays • Length 2:58Download video MP4
Download video MP3
Similar videos
-
1:18
preliminary results of a phase ib study combining abt-199 and obinutuzumab in cll
-
3:15
overview of a phase ib study of venetoclax and obinutuzumab in cll
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
4:55
results of the phase ib/ii trial of obinutuzumab-atezolizumab-lenalidomide for r/r fl
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
23:23
identifying and treating high-risk patients in 2023
-
2:39
the safety and efficacy of ibrutinib for the treatment of cll
-
4:08
phase ib trial of ianalumab plus ibrutinib for cll
-
2:43
four-year follow-up from a phase ii study of obinutuzumab, ibrutinib, and venetoclax in cll
-
4:43
phase ib trial of ianalumab plus ibrutinib for cll
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
1:12
cpx-351 with venetoclax in r/r aml: results of a phase ib study
-
0:49
overview of the cll2-big trial of ibrutinib and obinutuzumab
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
2:55
clinical outcomes of patients with cll receiving long-term ibrutinib in the resonate-2 study
-
2:57
the cll12 trial of ibrutinib in early stage cll
-
2:37
allo-hsct for cll in the era of novel agents
-
1:43
results from a phase ii trial of pirtobrutinib, venetoclax, and obinutuzumab in cll
-
1:23
interim analysis of the flair study: efficacy of ibrutinib plus venetoclax in ighv unmutated cll